Showing results (261-270 of 472) with videos related to
Sort By:
Pageof 48
Therapeutic Advances in Cardiovascular Disease|January 7, 2009
Carotid intima-media thickness and plaque volume changes following 2-year angiotensin II-receptor blockade. The Multicentre Olmesartan atherosclerosis Regression Evaluation (MORE) studyKlaus O Stumpe, Enrico Agabiti-Rosei, Tomasz Zielinski, et al.Therapeutic Advances in Cardiovascular Disease|January 7, 2009
New approaches to the assessment of left ventricular hypertrophyEnrico Agabiti-Rosei, Maria Lorenza Muiesan, Massimo SalvettiTherapeutic Advances in Cardiovascular Disease|January 7, 2009
Capillary rarefaction in treated and untreated hypertensive subjectsCynthia Cheng, Constantine Daskalakis, Bonita FalknerTherapeutic Advances in Cardiovascular Disease|January 7, 2009
Endurance exercise and resistance training in cardiovascular diseaseNaga Meka, Srikanth Katragadda, Biju Cherian, et al.Therapeutic Advances in Cardiovascular Disease|January 7, 2009
Avoiding restenosis: is there a role for glucocorticoids in the drug-eluting stent era?Santiago Jimenez-Valero, Raul Moreno, Angel Sanchez-Recalde, et al.Therapeutic Advances in Cardiovascular Disease|January 7, 2009
Prevention of coronary heart disease in womenRohit Seth Loomba, Rohit AroraTherapeutic Advances in Cardiovascular Disease|January 7, 2009
New techniques for assessment of vascular functionRonald D Smith, Pavel J LevyTherapeutic Advances in Cardiovascular Disease|January 7, 2009
Elevated infection parameters and infection symptoms predict an acute coronary eventErkki Pesonen, Eva Andsberg, Anders Grubb, et al.Therapeutic Advances in Cardiovascular Disease|January 7, 2009
Thiazolidinedione associated volume overload and pulmonary hypertensionJeffrey MichaelsonTherapeutic Advances in Cardiovascular Disease|January 7, 2009
Monitoring oral antiplatelet therapy: is it justified?Lawrence Ang, Ehtisham MahmudPageof 48